APA (7th ed.) Citation

PA, B., HEG, W., JA, S., G, K., & WB, E. (2025). Preclinical Evaluation of an Anti-EphA2 Minibody-Based ImmunoPET Agent as a Diagnostic Tool For Cancer. Molecular imaging and biology, 27(6), 993. https://doi.org/10.1007/s11307-025-02048-7

Chicago Style (17th ed.) Citation

PA, Birikorang, Wedaarachchi HEG, Smith JA, Kohanbash G, and Edwards WB. "Preclinical Evaluation of an Anti-EphA2 Minibody-Based ImmunoPET Agent as a Diagnostic Tool For Cancer." Molecular Imaging and Biology 27, no. 6 (2025): 993. https://doi.org/10.1007/s11307-025-02048-7.

MLA (9th ed.) Citation

PA, Birikorang, et al. "Preclinical Evaluation of an Anti-EphA2 Minibody-Based ImmunoPET Agent as a Diagnostic Tool For Cancer." Molecular Imaging and Biology, vol. 27, no. 6, 2025, p. 993, https://doi.org/10.1007/s11307-025-02048-7.